Acetates/therapeutic use; Aortic Diseases/drug therapy; Atherosclerosis/drug therapy; Heptanoic Acids/therapeutic use; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hyperlipidemias/drug therapy; Pyrroles/therapeutic use; Sterol O-Acyltransferase/antagonists & inhibitors; Sulfonic Acids/therapeutic use; Acetamides; Acetates/administration & dosage; Animals; Aorta, Abdominal/enzymology; Aorta, Abdominal/injuries; Aorta, Abdominal/pathology; Aortic Diseases/enzymology; Aortic Diseases/etiology; Aortic Diseases/pathology; Atherosclerosis/enzymology; Atherosclerosis/etiology; Atherosclerosis/pathology; Atherosclerosis/prevention & control; Atorvastatin; Catheterization/adverse effects; Cholesterol/blood; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids/administration & dosage; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage; Hyperlipidemias/blood; Hyperlipidemias/complications; Hyperlipidemias/genetics; Magnetic Resonance Imaging; Matrix Metalloproteinase 1/analysis; Matrix Metalloproteinase 3/analysis; Pyrroles/administration & dosage; Rabbits; Random Allocation; Sulfonamides; Sulfonic Acids/administration & dosage